Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Madeleine A. Ochs"'
Autor:
Madeleine A. Ochs, Bernard L. Marini, Anthony J. Perissinotti, Charles E. Foucar, Kristen Pettit, Patrick Burke, Dale L. Bixby, Lydia L. Benitez
Publikováno v:
Annals of Hematology. 101:1627-1644
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::571ba1deb6fe8752979cabb0971e5bcf
https://doi.org/10.1007/s00277-022-04872-1
https://doi.org/10.1007/s00277-022-04872-1
Autor:
Madeleine A. Ochs, Bernard L. Marini, Lydia L. Benitez, Sarah E. Stump, Taylor M. Weis, Kaitlyn M. Buhlinger, Thomas Diaz, Justin H. Reid, Benyam Muluneh, Kristen Pettit, Patrick Burke, Dale L. Bixby, Anthony J. Perissinotti
Publikováno v:
Leukemia & Lymphoma. 63:1839-1848
Patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) represent a heterogeneous population and therefore there is no standard of care first salvage regimen. We conducted a multicenter, retrospective analysis to compare chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b126278851bc6a8ca7a1b97b0cb74ae
https://doi.org/10.1080/10428194.2022.2053530
https://doi.org/10.1080/10428194.2022.2053530
Autor:
Madeleine A, Ochs, Bernard L, Marini, Anthony J, Perissinotti, Charles E, Foucar, Kristen, Pettit, Patrick, Burke, Dale L, Bixby, Lydia L, Benitez
Publikováno v:
Annals of hematology. 101(8)
In recent years, an explosion of novel agents has shifted the treatment paradigm for patients with acute myeloid leukemia. The optimal place in therapy for many of these novel agents remains unknown due to limited guidance from national guidelines an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d36d1972a062a1e2a0946593869c705
https://pubmed.ncbi.nlm.nih.gov/35618780
https://pubmed.ncbi.nlm.nih.gov/35618780
Publikováno v:
Pediatric pulmonologyREFERENCES. 56(12)
Aminoglycosides are commonly used for the treatment of Pseudomonas aeruginosa (PsA) in the setting of acute pulmonary exacerbations (PEx) in pediatric patients with cystic fibrosis (CF). There are controversies and practice differences between instit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b05caa97be71078a7f2491ab7a3feb
https://pubmed.ncbi.nlm.nih.gov/33983680
https://pubmed.ncbi.nlm.nih.gov/33983680
Autor:
Madeleine A. Ochs, Bernard L. Marini, Lydia L. Benitez, Anthony J. Perissinotti, Patrick W. Burke, Kristen Pettit, Dale L. Bixby
Publikováno v:
Leukemia Research. 102:106517
High dose cytarabine (HIDAC) consolidation has demonstrated a survival benefit in patients with acute myeloid leukemia (AML). The increasing prevalence of obesity and the toxicity risk with this therapy renders important the quantification of potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08e674be831d79edcf052eb9f1cd032
https://doi.org/10.1016/j.leukres.2021.106517
https://doi.org/10.1016/j.leukres.2021.106517